Evidence map›Paper›PMID 31624705›Full record

ArticleTissue engineering and regenerative medicine2019

Induced Intermediate Mesoderm Combined with Decellularized Kidney Scaffolds for Functional Engineering Kidney.

Jianye Zhang, Kailin Li, Feng Kong, Chao Sun, Denglu Zhang, Xin Yu, Xuesheng Wang, Xian Li, Tongyan Liu, Guangfeng Shao and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Decellularized rat tubules for tissue engineering.Translational andrology and urology · 2025
    Article
  3. Article
  4. Review
  5. [Development and prospect of tissue engineering in urology].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jianye Zhang1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.ORCID 0000-0002-0223-0569
Kailin Li2Department of Central Research Lab, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Feng Kong2Department of Central Research Lab, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Chao Sun2Department of Central Research Lab, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Denglu Zhang5The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Jinan, 250011 Shandong People's Republic of China.
Xin Yu1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Xuesheng Wang1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Xian Li6The Second Hospital of Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Tongyan Liu6The Second Hospital of Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Guangfeng Shao1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Yong Guan1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Shengtian Zhao1Department of Urology, The Second Hospital, Shandong University, 247 Beiyuan Street, Jinan, 250033 Shandong People's Republic of China.
Second Hospital of Shandong University · CNShandong University · CNShandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic kidney disease is a severe threat to human health with no ideal treatment strategy. Mature mammalian kidneys have a fixed number of nephrons, and regeneration is difficult once they are damaged. For this reason, developing an efficient approach to achieve kidney regeneration is necessary. The technology of the combination of decellularized kidney scaffolds with stem cells has emerged as a new strategy; however, in previous studies, the differentiation of stem cells in decellularized scaffolds was insufficient for functional kidney regeneration, and many problems remain. Methods: We used 0.5% sodium dodecyl sulfate (SDS) to produce rat kidney decellularized scaffolds, and induce adipose-derived stem cells (ADSCs) into intermediate mesoderm by adding Wnt agonist CHIR99021 and FGF9 Results: Intermediate mesoderm cells were successfully induced from ADSCs and identified by immunofluorescence and Western blotting assays (OSR1 + , PAX2 +). Immunofluorescence showed that intermediate mesoderm cells differentiated into tubular-like (E-CAD + , GATA3 +) and podocyte-like (WT1 +) cells with higher differentiation efficiency than ADSCs in the decellularized scaffolds. Comparatively, this phenomenon was not observed in induced intermediate mesoderm cells cultured Conclusion: In this study, we demonstrated that intermediate mesoderm cells could be induced from ADSCs and that they could differentiate well after cocultured with decellularized scaffolds.

Indexed as

AnimalsElectrophoresis, Polyacrylamide GelFibroblast Growth Factor 9Fluorescent Antibody TechniqueKidneyMesodermPyridinesPyrimidinesRatsTissue EngineeringChir 99021Fibroblast Growth Factor 9PyridinesPyrimidinesAdipose-derived stem cellsDecellularized scaffoldsInduced differentiationIntermediate mesoderm cellsKidney regeneration

Identifiers

PMID31624705
PMCPMC6778583
OpenAlexW2949609076

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.